Notices. Notice; correction
226 words·~1 min read·
/register/2019/07/05/2019-14362·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4163-18-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2017-D-4303] Providing Regulatory Submissions in Electronic Format—Content of the Risk Evaluation and Mitigation Strategies Document Using Structured Product Labeling; Draft Guidance for Industry; Availability; Correction AGENCY: Food and Drug Administration, HHS. ACTION: Notice; correction. SUMMARY: The Food and Drug Administration is correcting a notice entitled “Providing Regulatory Submissions in Electronic Format—Content of the Risk Evaluation and Mitigation Strategies Document Using Structured Product Labeling;
Draft Guidance for Industry; Availability” that appeared in the **Federal Register** of September 5, 2017. The document announced the availability of a guidance for industry. The document was published with the incorrect docket number. This document corrects that error. Previously submitted comments will be transferred to the correct docket number. FOR FURTHER INFORMATION CONTACT: Lisa Granger, Office of Policy, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 3330, Silver Spring, MD 20993-0002, 301-796-9115.
SUPPLEMENTARY INFORMATION: In the **Federal Register** of Tuesday, September 5, 2017 (82 FR 41968), in FR Doc. 2017-18506, the following correction is made: On page 41968, in the first column, in the header of the document, and in the second column, under *Instructions,* “[Docket No. FDA-2017-E-4282]” is corrected to read “[Docket No. FDA-2017-D-4303].” Dated: July 1, 2019. Lowell J. Schiller, Principal Associate Commissioner for Policy. [FR Doc. 2019-14362 Filed 7-3-19; 8:45 am]